Gene · 4050
Papers2,481
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,481
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine. | Vaccine | 2022 | 35078662 | PubTator, text mining | PubMed |
| Cellular architecture of human brain metastases. | Cell | 2022 | 35063085 | PubTator, text mining | PubMed |
| Plant-Based Vaccines: Antigen Design, Diversity, and Strategies for High Level Production. | Vaccines (Basel) | 2022 | 35062761 | PubTator, text mining | PubMed |
| An atlas of dynamic peripheral blood mononuclear cell landscapes in human perioperative anaesthesia/surgery. | Clin Transl Med | 2022 | 35061932 | PubTator, text mining | PubMed |
| Importance of cortactin for efficient epithelial NF-ĸB activation by Helicobacter pylori, Salmonella enterica and Pseudomonas aeruginosa, but not Campylobacter spp. | Eur J Microbiol Immunol (Bp) | 2022 | 35060920 | PubTator, text mining | PubMed |
| Receptor Specificity Engineering of TNF Superfamily Ligands. | Pharmaceutics | 2022 | 35057080 | PubTator, text mining | PubMed |
| A Unique Immune-Related Gene Signature Represents Advanced Liver Fibrosis and Reveals Potential Therapeutic Targets. | Biomedicines | 2022 | 35052861 | PubTator, text mining | PubMed |
| Hemodialysis and Plasma Oxylipin Biotransformation in Peripheral Tissue. | Metabolites | 2022 | 35050156 | PubTator, text mining | PubMed |
| Aging-related cell type-specific pathophysiologic immune responses that exacerbate disease severity in aged COVID-19 patients. | Aging Cell | 2022 | 35023286 | PubTator, text mining | PubMed |
| Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia. | Blood Cancer Discov | 2022 | 35019859 | PubTator, text mining | PubMed |
| Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia. | J Immunother Cancer | 2022 | 35017151 | PubTator, text mining | PubMed |
| Comprehensive analysis of a TNF family based-signature in diffuse gliomas with regard to prognosis and immune significance. | Cell Commun Signal | 2022 | 35000592 | PubTator, text mining | PubMed |
| Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins. | Vaccine | 2022 | 34998606 | PubTator, text mining | PubMed |
| In situ analysis of variations of arsenicals, microbiome and transcriptome profiles along murine intestinal tract. | J Hazard Mater | 2022 | 34876320 | PubTator, text mining | PubMed |
| Information flow in the spatiotemporal organization of immune responses. | Immunol Rev | 2022 | 34845729 | PubTator, text mining | PubMed |
| Novel drug developmental strategies for treatment-resistant depression. | Br J Pharmacol | 2022 | 34822719 | PubTator, text mining | PubMed |
| An integrative epi-transcriptomic approach identifies the human cartilage chitinase 3-like protein 2 (CHI3L2) as a potential mediator of B12 deficiency in adipocytes. | Epigenetics | 2022 | 34818986 | PubTator, text mining | PubMed |
| Nasal immune gene expression in response to azelastine and fluticasone propionate combination or monotherapy. | Immun Inflamm Dis | 2022 | 34813682 | PubTator, text mining | PubMed |
| A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation. | J Invest Dermatol | 2022 | 34808233 | PubTator, text mining | PubMed |
| A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients. | J Exp Med | 2022 | 34807232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4050/papers?page=33